Citadel Advisors
ELX

Citadel Advisors’s EMULEX CORP ELX Stock Holding History

Citadel Advisors’s Portfolio ELX Stock Details ELX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-20,188
Closed -$161K – 9462
2015
Q1 		$161K Sell
20,188
-156,959
-89% -$1.1M ﹤0.01% 6419
2014
Q4 		$1M Buy
177,147
+168,990
+2,072% +$911K ﹤0.01% 3768
2014
Q3 		$40K Sell
8,157
-104,518
-93% -$566K ﹤0.01% 7055
2014
Q2 		$642K Sell
112,675
-217,259
-66% -$1.29M ﹤0.01% 4069
2014
Q1 		$2.44M Buy
329,934
+323,425
+4,969% +$2.38M ﹤0.01% 2448
2013
Q4 		$47K Sell
6,509
-11,244
-63% -$83.5K ﹤0.01% 6089
2013
Q3 		$138K Buy
17,753
+12,997
+273% +$101K ﹤0.01% 5097
2013
Q2 		$31K Buy
+4,756
New +$29.9K ﹤0.01% 5891

Citadel Advisors's ELX Position: Q2 2015 in Review

Citadel Advisors sold out of EMULEX CORP (ELX) in Q2 2015, closing a stake of 20,188 shares — an estimated $161K sold.

Citadel Advisors first reported a position in ELX in Q2 2013 and held it in 8 quarters. The position peaked at $2.44M in Q1 2014. 0 funds tracked by Wall St. Rank hold ELX as of Q2 2015.

  • Citadel Advisors reported no remaining EMULEX CORP position as of Q2 2015 after selling out during the quarter.
  • Citadel Advisors sold 20,188 EMULEX CORP shares in Q2 2015, an estimated $161K.
  • Citadel Advisors first reported a position in EMULEX CORP in Q2 2013 and held it in 8 quarters.
  • Citadel Advisors's EMULEX CORP position peaked at $2.44M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held EMULEX CORP as of Q2 2015.

Based on Citadel Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.